Activist Jorey Chernett Boosts Stake to 15.17% with Over $1M in Recent Purchases
STIM sits 57% above its 52-week low of $0.8 on light trading volume (0.3× avg).
Summary
Activist investor Jorey Chernett has increased his stake in Neuronetics to 15.17% through recent purchases totaling over $1 million, signaling continued conviction in his activist agenda.
Key Events · Ownership and Investor Activity · STIM
-
Activist Stake Increased
Jorey Chernett, an activist investor, has increased his beneficial ownership in Neuronetics, Inc. to 15.17% of the outstanding common stock.
-
Significant Recent Purchases
Since the last amendment, Chernett purchased an additional 775,000 shares for approximately $1.06 million, with transactions occurring between April 20 and May 19, 2026.
-
Reinforces Prior Demands
This increased stake by Chernett, who previously demanded a comprehensive strategic review, signals strong conviction in his activist position and potential for further engagement.
Analysis · STIM · Industrial Applications And Services
Activist investor Jorey Chernett has significantly increased his ownership in Neuronetics, purchasing an additional $1.06 million worth of shares. This move raises his total stake to 15.17% and reinforces his position as a major shareholder, particularly after his previous demands for a comprehensive strategic review of the company. The continued accumulation by an activist suggests strong conviction in his proposed changes or the company's underlying value.
How filings like this one have moved
In the 30 days to Sep 19, 2026, 34.7% of the 1096 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STIM was trading at $1.26 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $87.3M. The 52-week trading range was $0.80 to $4.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.